Clinical trial
Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving…
NCT00183677 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00183677 |
|---|---|
| Title | Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram |
| Official title | Biochemical Brain Changes Correlated With the Antidepressant Effect of Escitalopram: A Magnetic Resonance Spectroscopic Imaging Study |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 97 |
| Start date | Jul 1, 2003 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: